£76.37

Springer Perugia Consensus Conference on Antiemetic Therapy

Price data last checked 51 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 40 days • 40 data points (No recent data available)

Historical
Generating forecast...
£76.37 £72.25 £73.15 £74.05 £74.95 £75.85 £76.75 28 January 2026 06 February 2026 16 February 2026 26 February 2026 08 March 2026

Price Distribution

Price distribution over 40 days • 2 price levels

Days at Price
Current Price
36 days 4 days · current 0 9 18 27 36 £73 £76 Days at Price

Price Analysis

Most common price: £73 (36 days, 90.0%)

Price range: £73 - £76

Price levels: 2 different prices over 40 days

Description

Product Description In the last decade, important progress has been achieved in the prevention of chemotherapy-induced nausea and vomiting, in particular since the introduction of 5-HT3 antagonists which, when used in combination with steroids, can assure significant protection in the majority of patients. Nonetheless, for some relevant clinical problems there still is no satisfactory answer, and there are major differences in clinical practice regarding antiemetic use. This volume contains the results of the fifth Perugia International Cancer Conference which was organized in 8 sessions, a consensus document was prepared for each session forming a useful basis for future developments. From the Back Cover In the last decade, important progress has been achieved in the prevention of chemotherapy-induced nausea and vomiting, in particular since the introduction of 5-HT3 antagonists which, when used in combination with steroids, can assure significant protection in the majority of patients. Nonetheless, for some relevant clinical problems there still is no satisfactory answer, and there are major differences in clinical practice regarding antiemetic use. This volume contains the results of the fifth Perugia International Cancer Conference which was organized by the anti-emetic subcommittee of MASCC (Multinational Association of Supportive Care in Cancer). A consensus document was prepared for each session forming a useful basis for future developments.

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
10 December 2011
Listed Since
12 July 2012

Barcode

No barcode data available

Similar Products You Might Like

Ondansetron and chemotherapy induced emesis: 3rd International Congress on Neo-adjuvant Chemotherapy
94% match

Ondansetron and chemotherapy induced emesis: 3rd International Congress on Neo-adjuvant Chemotherapy

Springer

£84.72 01 Mar 2026
Critical Issues in Head and Neck Oncology: Key concepts from the Fifth THNO Meeting
91% match

Critical Issues in Head and Neck Oncology: Key concepts from the Fifth THNO Meeting

Springer

£162.77 12 Jan 2026
Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy (Volume 18) (Cancer Sensitizing Agents for Chemotherapy, Volume 18)
91% match

Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy (Volume 18) (Cancer Sensitizing Agents for Chemotherapy, Volume 18)

Academic Press

£115.58 10 Mar 2026
Chemotherapy Protocols and Infusion Sequence: Schedule Consideration in Cancer Treatment
91% match

Chemotherapy Protocols and Infusion Sequence: Schedule Consideration in Cancer Treatment

£72.98 09 Jan 2026
Humana Cancer Neurology in Clinical Practice Medical Book
91% match

Humana Cancer Neurology in Clinical Practice Medical Book

Humana

£111.57 13 Apr 2026
Acupuncture and Moxibustion as an Evidence-based Therapy for Cancer: 3 (Evidence-based Anticancer Complementary and Alternative Medicine, 3)
91% match

Acupuncture and Moxibustion as an Evidence-based Therapy for Cancer: 3 (Evidence-based Anticancer Complementary and Alternative Medicine, 3)

Springer

£128.11 09 Jan 2026
Evidence-based Anticancer Materia Medica (Evidence-based Anticancer Complementary and Alternative Medicine)
91% match

Evidence-based Anticancer Materia Medica (Evidence-based Anticancer Complementary and Alternative Medicine)

Springer

£149.32 11 Jan 2026
Cancer Neurology in Clinical Practice: Neurological Complications of Cancer and its Treatment
91% match

Cancer Neurology in Clinical Practice: Neurological Complications of Cancer and its Treatment

Springer

£124.50 07 Feb 2026
Neurological Adverse Reactions to Anticancer Drugs (ESO Monographs)
91% match

Neurological Adverse Reactions to Anticancer Drugs (ESO Monographs)

Springer

£113.05 10 Feb 2026
Cancer Chemoprevention and Treatment by Diet Therapy: 5 (Evidence-based Anticancer Complementary and Alternative Medicine, 5)
91% match

Cancer Chemoprevention and Treatment by Diet Therapy: 5 (Evidence-based Anticancer Complementary and Alternative Medicine, 5)

Springer

£113.11 14 Jan 2026
Evidence-based Anticancer Materia Medica: 0 (Evidence-based Anticancer Complementary and Alternative Medicine)
91% match

Evidence-based Anticancer Materia Medica: 0 (Evidence-based Anticancer Complementary and Alternative Medicine)

Springer

£130.00 11 Jan 2026
Regional Chemotherapy: Clinical Research and Practice (Current Clinical Oncology)
91% match

Regional Chemotherapy: Clinical Research and Practice (Current Clinical Oncology)

Humana

£85.07 13 Apr 2026
Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)
90% match

Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)

Springer

£110.00 10 Mar 2026
Gastric Cancer In The Precision Medicine Era: Diagnosis and Therapy (Current Clinical Pathology)
90% match

Gastric Cancer In The Precision Medicine Era: Diagnosis and Therapy (Current Clinical Pathology)

Humana

£88.34 01 Mar 2026
Cardiotoxicity of Chemotherapeutic Agents (Cancer Etiology, Diagnosis and Treatments: Cardiology Research and Clinical Developments)
90% match

Cardiotoxicity of Chemotherapeutic Agents (Cancer Etiology, Diagnosis and Treatments: Cardiology Research and Clinical Developments)

£162.82 12 Jan 2026
Materia Medica for Various Cancers: 2 (Evidence-based Anticancer Complementary and Alternative Medicine, 2)
90% match

Materia Medica for Various Cancers: 2 (Evidence-based Anticancer Complementary and Alternative Medicine, 2)

Springer

£129.10 12 Feb 2026
Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)
90% match

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)

Springer

£146.40 25 Jan 2026
Side Effects of Medical Cancer Therapy: Prevention and Treatment
90% match

Side Effects of Medical Cancer Therapy: Prevention and Treatment

Springer

£87.99 27 Mar 2026
Springer Cancer Chemotherapy Volume 36 - Research Series
90% match

Springer Cancer Chemotherapy Volume 36 - Research Series

Springer

£113.25 05 Mar 2026
The MASCC Textbook of Cancer Supportive Care and Survivorship
90% match

The MASCC Textbook of Cancer Supportive Care and Survivorship

Springer

£151.04 10 Mar 2026
Personalized Cancer Chemotherapy: An Effective Way of Enhancing Outcomes in Clinics
90% match

Personalized Cancer Chemotherapy: An Effective Way of Enhancing Outcomes in Clinics

Woodhead Publishing

£111.97 19 Apr 2026
Principles and Practice of Palliative Care and Support Oncology
90% match

Principles and Practice of Palliative Care and Support Oncology

WOLTERS KLUWER HEALTH

£144.26 18 Mar 2026
Pharmaceutical Perspectives of Cancer Therapeutics
90% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£139.95 11 Jan 2026
Concise Manual of Hematology and Oncology
90% match

Concise Manual of Hematology and Oncology

Springer

£135.17 24 Jan 2026